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Summary:  Enzymes that increase the chain length of fatty acids are essential for 
biosynthesis of highly unsaturated fatty acids.  The gLELO gene encodes a protein 
involved in the elongation of polyunsaturated fatty acids in the fungus Mortierella 
alpina.  A search of the Genbank database identified several EST sequences, 
including one obtained from zebrafish (Danio rerio), with high similarity to gLELO.  
The full-length transcript, ZfELO, encoding a polypeptide of 291 amino acid residues 
was isolated from zebrafish liver cDNA.  The predicted amino acid sequence of the 
open reading frame (ORF) shared high similarity with the elongases of C. elegans and 
human.  When expressed in Saccharomyces cerevisiae, the zebrafish ORF conferred 
the ability to lengthen the chain of a range of C18, C20 and C22 polyunsaturated fatty 
acids, indicating that biosynthesis of 22:6n-3 from 18:3n-3 via a 24-carbon 
intermediate is not only feasible, but that one elongase enzyme can perform all three 
elongation steps required. The zebrafish enzyme was also able to elongate 
monounsaturated and saturated fatty acids, and thus demonstrates a greater level of 
promiscuity in terms of substrate use than any elongase enzyme described previously.  
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INTRODUCTION 
The long-chain highly unsaturated fatty acids (HUFA) arachidonic acid (AA; 20:4n-
6), eicosapentaenoic acid (EPA; 20:5n-3) and docosahexaenoic acid (DHA; 22:6n-3) 
are essential for normal cellular function, being important constituents of membrane 
phospholipids, affecting membrane fluidity, and the activity of membrane proteins 
involved in transport, signal transduction and various enzymic reactions (Mcmurchie, 
1988). DHA and AA, have important roles in the development and function of neural 
tissues (Innis et al., 1999), and EPA and AA are precursors of eicosanoids, that 
modulate many physiological processes including reproduction, haemostasis and 
inflammation (Weber, 1990).  Increased dietary levels of the n-3HUFA, EPA and 
DHA, have significant beneficial health effects in relation to cardiovascular, immune 
and inflammatory conditions (Knapp, 1999, 2001) and the importance of maintaining 
a balanced dietary intake of n-6 and n-3 HUFA for human health is well established 
(Anon., 1992). 
    The only major source of n-3HUFA for the human diet is fish and seafood and 
generally declining catches from wild fisheries have resulted in an increasing 
proportion of fish for human consumption being provided by aquaculture (Tidwell 
and Allan, 2002).  However, much aquaculture, including salmonid (salmon and 
trout) culture, is itself dependent upon wild capture fisheries for the provision of fish 
meals and oils that have traditionally been the predominant protein and lipid sources 
(Sargent and Tacon, 1999). However, stagnation in the industrial fisheries, along with 
the increased demand for fish oils, has dictated that alternatives to fish oil must be 
found if aquaculture is to continue to expand and supply more of the global demand 
for fish (Barlow, 2000).  The only sustainable alternative to fish oils are plant 
(vegetable) oils which are rich in C18 polyunsaturated fatty acids (PUFA) such as 
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18:2n-6 and 18:3n-3, but devoid of the n-3 HUFA abundant in fish oils (Sargent et al., 
2002).   
The extent to which animals, including fish, can convert C18 PUFA to C20/22 HUFA 
varies with species and correlates with their complement of active microsomal fatty 
acyl desaturase and elongase enzymes. Thus, EPA is synthesised from 18:3n-3 by 
desaturation at the ∆6 position, followed by a 2-carbon elongation, that is in turn 
followed by a further desaturation at the ∆5 position (Fig.1) Cook, 1996).  Synthesis 
of DHA requires further elongation and desaturation of EPA, that has been suggested 
to proceed via a C24 intermediate (Sprecher et al., 1995).  However, there is variation 
among vertebrate species in the ability to synthesise HUFA from the C18 PUFA.  In 
herbivores, whose diet is essentially deficient in HUFA, requirements for HUFA must 
be met by endogenous biosynthesis via desaturation and elongation of the copious C18 
PUFA in their plant diet.  Carnivores, however, are generally dependent on a dietary 
supply of HUFA, which may be a response to a diet rich in HUFA but relatively poor 
in C18 PUFA (Rivers et al., 1975, 1976).  This spectrum of HUFA biosynthesis ability 
may be reflected in, and possibly caused by, genetic variation in structure and 
function of genes encoding the key enzymes in the HUFA biosynthesis pathway.  
Such variation certainly occurs, as exemplified by the fact that both ∆5 and ∆6 fatty 
acid desaturase activities in zebrafish (Danio rerio) are properties of a single 
polypetide product of one gene (Hastings et al., 2001).  This is unlike the case in other 
systems studied in which the two desaturase activities are encoded by disparate genes 
(Aki et al., 1999; Cho et al., 1999a,b; Leonard et al., 2000a; Michaelson et al., 1998; 
Napier et al., 1998; Watts and Browse, 1998). 
Elongation of fatty acid, whether saturated, monounsaturated or polyunsaturated, 
involves four enzymic steps (Fig. 2).  The first step essentially effects chain 
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elongation by condensation of the activated fatty acid with malonyl-CoA (Cinti et al., 
1992).  This step is rate-limiting, and operates on substrates specified by a putative 
elongase polypeptide.  The subsequent three steps are in essence the reverse of β-
oxidation.  Biochemical studies have suggested that different elongase enzymes are 
involved in the elongation of saturated and unsaturated fatty acids (Sprecher, 1974; 
Prasad et al., 1986) and that there may be different enzymes catalysing the elongation 
of C18/20 PUFA and C22 PUFA (Luthria and Sprecher, 1997).  Recently, enzymes 
catalyzing the elongation of C18 PUFA have been cloned from the fungus Mortierella 
alpina (Parker-Barnes et al., 2000), the nematode Caenorhabditis elegans (Beaudoin 
et al., 2000), and humans (Leonard et al., 2000b). Variation in HUFA biosynthesis 
may also operate at the elongation steps as supported by the low C18-20 elongase 
activity in the fish species turbot (Scophthalmus maximus) (Ghioni et al., 1999), a 
carnivorous marine teleost that requires a dietary supply of HUFA for normal growth 
(Bell et al., 1985). 
In this report we describe an elongase (zfELO), cloned on the basis of sequence 
similarity to existing PUFA elongases, from zebrafish (Danio rerio), a model fish 
species that we have previously shown to possess a high capacity to biosynthesise 
DHA, and thus to thrive on a diet largely devoid of HUFA (Tocher et al., 2002). The 
zebrafish enzyme showed broad substrate specificity, elongating C18, C20 and C22 
PUFA, indicating that only one elongase enzyme is necessary for the production of 
DHA in zebrafish.  The zebrafish enzyme also elongated both saturated and 
monounsaturated fatty acids. 
MATERIALS AND METHODS 
Cloning of the PUFA elongase cDNA 
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The PUFA elongase sequence (AF206662) of M. alpina was used to query the 
GenBank EST database (at NCBI) for homologues using the tblastn programme.  
Several vertebrate ESTs, including one from zebrafish (GeneBank accession number 
BF157708), were identified that had high similarity to the query sequence.  The 
zebrafish EST sequence was used to design primers for 5’ RACE and 3’ RACE 
cloning of the full-length transcript from zebrafish liver cDNA using the SMART 
RACE system (Clontech Laboratories Inc., Palo Alto, USA).  PCR fragments were 
cloned into the Bluescript SKII vector, and the sequences were determined by 
standard dye terminator chemistry (Perkin Elmer, Applied Biosystems) following the 
manufacturer’s protocols.  Sequence analysis was performed using the EBI and NCBI 
suites of software. 
 
Heterologous expression of elongase ORFs in yeast 
The open reading frame (ORF) was amplified from zebrafish liver cDNA.  The 
sequence of the sense primer ZfEloXA (CGG AAT TCA AGC TTA AGA TGG 
AGA CGT TTA GTC A) contains an EcoRI site (underlined) and a Kozak translation 
initiation sequence (boldface).  The antisense primer ZfEloXB (CTC TAG ACT CGA 
GTC AAT CTG CTC GTG CTT TTC T) contains an XhoI site (underlined).  PCR 
was performed using high fidelity DNA polymerase mix (Roche Diagnostics Ltd., 
Lewes, UK) following the manufacturer’s instruction.  After PCR the DNA fragments 
were restricted with EcoRI and XhoI, ligated into a similarly treated yeast expression 
vector pYX222 (R&D Systems, Abingdon, UK), which was then used to transform 
Top10 E. coli competent cells.  Transformation of yeast with recombinant ZfELO-
pYX222 plasmids, yeast culture and fatty acid analysis were performed as described 
previously (Hastings et al., 2001). Triplicate cultures of recombinant yeast were 
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grown in Saccharomyces cerevisiae minimal medium-histidine(SCMM-his) supplemented 
with one of the following PUFA substrates; stearidonic acid (18:4n-3), γ-linolenic 
acid (18:3n-6), 20:5n-3, 20:4n-6, 22:5n-3 and 22:4n-6.  Approximately equal amounts 
of yeast cells were transferred into glass conical test tubes after determination of 
culture densities at OD600.  The cells were collected by centrifugation at 500 g for 2 
min, the pellets washed twice with 5 ml of ice-cold Hanks balanced salt solution and 
dried under a stream of oxygen - free nitrogen (OFN). 
Fatty acid analysis. Fatty acid methyl esters (FAME) were prepared by incubating 
the dried yeast cells directly with 1 ml of methylation reagent containing 10 % (v/v) 
concentrated HCl, 5 % (v/v) 2,2-dimethoxypropane and 85% (v/v) dry methanol  for 1 
hour at 85oC.  After incubation, FAME were extracted by the addition of 1 ml of 1% 
NaCl solution and 0.5 ml of hexane containing 0.01% butylated hydroxytoluene as 
antioxidant. The mixture was vigorously mixed and centrifuged at 600 × g for 5 min 
to promote phase separation.  The top phase was carefully removed and filtered 
through Whatman No. 1 filter paper into a clean glass test tube, and the solvent 
evaporated under a stream of OFN.  The FAME were purified by thin-layer 
chromatography and then resuspended in hexane, all as described previously (Tocher 
and Harvie, 1988).  FAME were separated in a Fisons GC8160 gas chromatograph 
equipped with a chemically bonded CP Wax 52CB fused silica wall coated capillary 
column (30 m × 0.32 mm i. d., Chrompack U.K. Ltd., London) with an on-column 
injection system and flame ionization detection. Hydrogen was used as carrier gas 
with an oven thermal gradient from an initial 50 ºC to 180 oC at 40 ºC/min, and then 
to a final temperature of 235 oC at 2 ºC/min.  Individual FAME were identified by 
comparison with known standards, with a well-characterized fish oil, and by reference 
to published data, as described previously (Tocher and Harvie, 1988).  FAME were 
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quantified using a directly linked PC operating Chrom-Card Software (Thermo-Quest 
Italia S.P.A., Milan, Italy). The proportion of substrate fatty acid converted to the 
longer chain fatty acid product was calculated from the gas chromatograms as 100 × 
[product area/(product area + substrate area)].  All solvents contained 0.01% butylated 
hydroxytoluene as an antioxidant. 
Gas chromatography-Mass Spectrometry (GC-MS).  The identities of fatty acids 
and positions of their double bonds were confirmed by subjecting the picolinyl esters 
to electron ionization (EI) GC-MS.  Free fatty acids were prepared from FAME by 
alkaline hydrolysis as described by Christie (1982).  Picolinyl esters were prepared by 
the method of Balazy and Nies (1989).  This involves activating the free fatty acid by 
reaction with 1,1’-carbonyldiimidazole to form the imidazolide, which then reacts 
with 3-(hydroxymethyl)pyridine under basic conditions to form the picolinyl ester. 
GC-MS of the picolinyl esters was performed using a Fisons GC8000 gas 
chromatograph coupled to an MD800 mass spectrometer (Fisons Instruments, 
Crawley, U.K.). The gas chromatograph was equipped with a fused silica capillary 
column (60 m × 0.32 mm i.d, 0.25 mm internal film thickness) coated with Zebron 
ZB-Wax (Phenomenex, Macclesfield, U.K.) and used helium as carrier gas.  Samples 
were applied using on-column injection with the oven temperature programmed to 
rise from 80 oC to 250 oC at 40 oC per minute. 
 
RESULTS 
The translated amino acid sequence of M. alpina elongase was used to interrogate the 
GenBank EST nucleotide sequence database.  This identified homologous sequences 
involved in PUFA chain elongation from mammals (Homo sapiens and Mus 
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musculus), birds (Gallus domesticus), amphibians (Xenopus spp) and fish (Danio 
rerio). The full length PUFA elongase cDNA sequence from zebrafish (zfELO; 
Genbank accession number AF532782) translated to a polypeptide of 291 amino acid 
residues, the sequence of which showed varying degrees of similarity with the 
sequences of elongases of other organisms, e.g., C. elegans (41%), M. alpina (48%), 
and Homo sapiens (87%) (Fig. 3). 
High fidelity PCR was used to amplify the coding DNA sequence (CDS) of the 
elongase gene using zebrafish liver cDNA as template.  After cloning into the 
pYX222 plasmid, the identity of the CDS was reconfirmed by sequencing before 
transforming yeast.  Heterologous expression of the zebrafish elongase ORF in S. 
cerevisiae in the presence of exogenous 18:4n-3 confirmed that the cDNA encoded a 
polypeptide that is a component of the PUFA chain elongation system of zebrafish 
(Fig. 4A).  Several PUFA were subsequently investigated as potential substrates, with 
all six fatty acids tested converted to the respective elongation products by 
recombinant yeast as follows: 18:4n-3→20:4n-3, 18:3n-6→20:3n-6, 20:4n-6→22:4n-
6, 20:5n-3→22:5n-3, 22:5n-3→24:5n-3 and 22:4n-6→24:4n-6 (Figs. 4A-C).  The 
identities of elongation products were confirmed by comparison with known 
standards and gas chromatography/mass spectrometry of picolinyl esters.  For 
example, the mass spectra for the products of elongation of C22 PUFA are shown in 
Fig.5.  The samples all showed prominent ions at m/z = 92, 108, 151 and 164, which 
are characteristic of picolinyl esters representing fragments about the pyridine ring 
(Fig.5) (Christie, 1998). The EI spectra of the additional fatty acid in ZfELO-pYX222 
transformed yeast incubated with 22:4n-6 showed a fragmentation pattern with a mass 
ion of 451 m/z and peaks at 436, 380, 354, 340, 314, 300, 274, 260 and 234 m/z (Fig. 
5A). The initial interval of 15 (451-436) represented the terminal methyl and was 
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followed by four intervals of 14 (436-380) indicating four methylene groups. The 
intervals of 26 (380-354, 340-314, 300-274 and 260-234) denoted the positions of 
four double bonds, indicating that this fatty acid is ∆18,15,12,924:4 = 24:4n-6 (Fig.5A).  
The EI spectra of the additional fatty acid from cells incubated with 22:5n-3 showed a 
mass ion of 449 m/z and fragments at 434, 420, 394, 380, 354, 340, 314, 300, 274, 
260 and 234 m/z The initial interval of 15 (449-434) represented the terminal methyl 
and was followed by an interval of 14 (434-420) indicating one methylene group. The 
intervals of 26 (420-394, 380-354, 340-314, 300-274 and 260-234) denoted the 
positions of five double bonds, confirming this fatty acid as ∆21,18,15,12,924:5 = 24:5n-3 
(Fig.5B).  
Generally, the efficiency of zfELO for the different PUFA substrates, as measured by 
the relative conversion, decreased with the substrate chain length, that is, C18 > C20 > 
C22 (Fig.6).  In addition, n-3 PUFA were more efficiently converted than the n-6 
PUFA of the same chain length.  Thus, the zebrafish elongase converted 90% of 
18:4n-3 to 20:4n-3 compared to 60% of 18:3n-6 converted to 20:3n-6.   
By comparing the fatty acid profiles of the recombinant yeast carrying the elongase 
with that of yeast carrying only the pYX222 plasmid, it was clear that endogenous 
fatty acids in the yeast were also elongated as follows: 16:0 → 18:0; 16:1n-7 →→→ 
18:1n-7 → 20:1n-7; and 18:1n-9 → 20:1n-9 (Table 1).  This indicates that the 
zebrafish elongase is also active on saturated and monounsaturated fatty acid 
substrates, albeit with lower efficiency than with PUFA substrates. Significant activity 
was also observed on 18:3n-3 which was converted to eicosatrienoic acid (20:3n-3), a 
so-called “dead-end” product (data not shown). 
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DISCUSSION 
Here we report the sequence and function of a cDNA, zfELO, derived from a gene 
that is responsible for the chain elongation of a range of PUFA in zebrafish, a model 
fresh water fish species.  The cDNA encodes a protein that is very similar to 
mammalian elongases, and has all the main structural characteristics possessed by 
elongases derived from other systems.  These include the predicted transmembrane 
domains, the so-called histidine box (HXXHH) and the canonical C-terminal 
endoplasmic reticulum (ER) retention signal. 
Functional characterisation has previously been reported for PUFA elongases of 
nematode (C. elegans), fungus, (M. alpina), rat and human with all four enzymes 
being predominantly active on C18 PUFA (Beaudoin et al., 2000; Leonard et al., 
2000b; Parker-Barnes et al., 2000; Inagaki et al. 2002).  This was also the case with 
zebrafish elongase, the enzyme achieving 90% conversion of 18:4n-3 substrate and 
60% of 18:3n-6.  Due to the very high activity of the zebrafish elongase towards C18 
PUFA, the highest activity observed, we suggest that the primary role of zfELO is as 
a PUFA elongase involved in the production of HUFA from C18 PUFA.  The 
zebrafish enzyme also had substantial C20 PUFA elongase activity, converting some 
46% and 26% of 20:5n-3 and 20:4n-6, respectively, to the respective C22 products.  
This is similar to human (ELOVL5) and rat elongases (rELO1), which also have high 
activity on 20:5n-3 and 20:4n-6 (Leonard et al., 2000b: Inagaki et al., 2002), but in 
contrast to the elongases of M. alpina and C. elegans which show virtually no activity 
towards C20 PUFA (Parker-Barnes et al., 2000; Beaudoin et al., 2000).  However, in 
contrast to the previously reported human and rat elongases described above, the 
zebrafish elongase also displayed the capacity to elongate C22 PUFA, converting 
about 5% of 22:5n-3 to 24:5n-3 in the recombinant yeast system studied. 
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That zebrafish elongase can chain elongate C18, C20 and C22 PUFA is significant for 
two reasons. The first is simply the fact that 22:5n-3 is elongated to 
tetracosapentaenoic acid (24:5n-3).  Direct synthesis of DHA from 22:5n-3 would 
require desaturation at the ∆4 position.  While a ∆4 desaturase has been described in 
the marine microheterotroph, Thraustochytrium sp (Qui et al., 2001), desaturation of 
PUFA at the ∆4 position has not been conclusively demonstrated in any vertebrate 
system.  Moreover, a search of the human genome sequence using the sequence of the 
Thraustochytrium sp ∆4 desaturase as query returned no positive result.  The work of 
Sprecher and colleagues indicated that synthesis of DHA in rat liver proceeded via 
C24 PUFA intermediates through two sequential elongations of 20:5n-3 to produce 
24:5n-3, which is then desaturated to 24:6n-3 before being chain shortened to 22:6n-3 
(Sprecher et al., 1995).  Therefore, 24:5n-3 is an important intermediate in the 
biosynthesis of DHA in vertebrates, and so its production by the action of the 
zebrafish elongase on either EPA or 22:5n-3 is significant.  Secondly, however, the 
zebrafish elongase is very active towards 18:4n-3, and so it is possible that only this 
single elongase enzyme is required to perform all the elongation steps required for the 
synthesis of DHA from 18:3n-3.  Furthermore, the desaturase we cloned previously 
from zebrafish expressed both ∆5 and ∆6 fatty acid desaturase activities (Hastings et 
al., 2001) and is also capable of desaturating 24:5n-3 to 24:6n-3 (Tocher et al., in 
press).  Therefore, zebrafish would appear to be able to perform all six 
desaturation/elongation reactions necessary for the production of DHA from 18:3n-3 
using just two gene products.  This is in contrast to all other vertebrate and eukaryotic 
systems studied in which desaturase activities are encoded by disparate genes (Aki et 
al., 1999; Cho et al., 1999a,b; Leonard et al., 2000a; Michaelson et al., 1998; Napier 
et al., 1998; Watts and Browse, 1998). 
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Very recently, two mammalian genes have been cloned and characterized, a further 
human elongase (ELOVL2) and a mouse elongase (elovl2), both of which were able 
to elongate 22:5n-3 and 22:4n-6 to 24:5n-3 and 24:4n-6, respectively  (Leonard et al., 
2002).  Like the zebrafish enzyme, the mouse elovl2 clone was also able to elongate 
C18 and C20 PUFA,  whereas the human ELOVL2 clone was only active towards C20 
and C22 PUFA (Leonard et al., 2002).  Neither the elovl2 or ELOVL2 clones showed 
any significant activity towards saturated or monounsaturated fatty acids (Leonard et 
al., 2002).  However, the previously cloned human elongase, ELOVL5, elongated 
monounsaturated fatty acids in addition to C18 and C20 PUFA (Leonard et al., 2000b).  
Thus, the two human elongases display different but overlapping substrate 
specificities.  Similarly, the two rat elongases display overlapping substrate 
preferences with rELO1 displaying a substrate specificity similar to that of human 
ELOVL5 (monounsaturated fatty acids and PUFA), whereas rELO2 elongated 
saturated and monounsaturated fatty acids with very little activity towards C18 PUFA, 
but no activity towards C20 and C22 PUFA (Inagaki et al., 2002). 
Thus, vertebrate fatty acid elongases display quite broad substrate specificities 
depending upon both chain length and degree of unsaturation.  The zebrafish elongase 
is entirely consistent in this respect, but appears to be unique in its capacity to 
elongate saturated and monounsaturated fatty acids, and PUFA with chain lengths 
from C18 up to and including C22.  Whether this is a reflection of the position of 
zebrafish in evolutionary history and hierarchy in comparison to mammals is unclear.  
However, it is noteworthy that the situation described with the fatty acid elongase of 
zebrafish is to some degree analogous to the previously described situation with the 
zebrafish fatty acid desaturase.  Indeed as zfELO also elongates saturated and 
monounsaturated fatty acids, it is interesting to speculate on the precise role(s) of this 
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gene in zebrafish, although the very high activity towards C18 PUFA suggests that its 
primary role is in PUFA metabolism.  However, the existence of more than one PUFA 
elongase in rat and human suggests that other elongases with differing substrate 
specificities may yet be isolated in zebrafish. 
The cloning and characterisation of the zebrafish PUFA elongase, along with the 
other elongases cloned from fungus, worm, rat and human, prompts the question of 
how the structural differences in elongase contribute directly to the inter-species 
variation in substrate specificity?  Clearly, the above discussion indicates that the 
primary structures of elongases must influence the range of fatty acid substrates 
accepted by the fatty acid chain elongation complex.  The number of different 
elongases with different and overlapping substrate specificities are now such that it 
may be possible to infer structure – function relationships, at least at the level of 
primary structure.  For instance, the sequences of human and fish elongases are very 
similar, but the differences that occur clearly affect the substrate range of the 
enzymes.  This presents an opportunity to study the structural features that have 
shaped fatty acid elongase substrate specificity during the evolution of vertebrates, 
and the possibility of artificially selecting for elongases with superior specification.  
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 Legends to Figures 
 
Figure 1. Schematic of DHA (22:6n-3) biosynthesis from α-linolenic acid (18:3n-3; 
ALA) in vertebrates. DHA is biosynthesized by sequential desaturation and 
elongation (ELO) of ALA. ∆4, ∆5 and ∆6 are desaturations at the respective chain 
positions.  The broken lines represent the alternative routes to DHA  postulated by  
Sprecher et al. (1995). 
 
Figure 2. Microsomal elongation of PUFA.  PUFA elongation is a multistep process.  
Step 1, which effects chain elongation through the condensation of a fatty acyl-CoA 
with malonyl-CoA is rate limiting and substrate specific as directed by the elongase 
polypeptide. Step 2-4 are acyl reductive processes. 
 
Figure 3. Comparison of the amino acid sequences of PUFA elongases cloned from 
Mortierella alpina (gLELO), Caenorhabditis elegans (CeLELO), Homo sapiens 
(HELO1) and Zebrafish (Danio rerio) (ZfELO). Identical residues are shaded black 
and similar residues are grey. The threshold for similarity shading was set at 75%. 
 
Figure 4. Identification of fatty acid elongation products in transgenic yeast 
(Saccharomyces cerevisiae). Fatty acids were extracted from yeast transformed with 
ZfELO-pYX222 grown in the presence of either A: 18:4n-3, B: 20:5n-3 or C: 22:5n-
3. The first four peaks in panels A-C are the main endogenous fatty acids of S. 
cerevisiae, namely 16:0 (1), 16:1n-7 (2), 18:0 (3) and 18:1n-9 (4). The additional 
peaks in  each panel are the exogenously added substrate fatty acids and the resultant 
elongated products, namely 18:4n-3 (5), 20:4n-3 (6), 20:5n-3 (7), 22:5n-3 (8) and 
24:5n-3 (9).  
 
Figure 5. Mass spectra of fatty acids (peaks) produced by yeast transformed with the 
ZfELO-pYX222 plasmid and grown in the presence of either A: 22:4n-6, or B: 22:5n-
3.   Picolinyl esters were prepared from fatty acid methyl esters derived from fatty 
acids extracted from the yeast and analyzed by GC-MS as described in the Methods 
section.  The mass spectra confirmed the product fatty acid identities as A: 24:4n-6, 
and B: 24:5n-3. 
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Figure 6. Relative activity of zebrafish elongase (ZfELO) towards various 
polyunsaturated fatty acids. The activity of ZfELO was assessed by  gas 
chromatographic analysis of the fatty acid composition of yeast (S. cerevisiae) cells 
containing the ZfELO-pYX222 plasmid grown in the presence of 0.5mM of γ-
linolenic acid (GLA), stearidonic acid (STA), arachidonic acid (AA), 
eicosapentaenoic acid (EPA), docosatetraenoic acid (DTA) and docosapentaenoic 
acid (DPA) respectively. The conversion rate was  calculated as 100 × [product area/ 
(product area + substrate area)]. 
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Fig.3.
GLELO MESIAPFLPSKMPQDLFMDLATAIGVRAAPYVDPLEAALVAQAEKYIPTIVHHTRGFLVAVESPLARELPLMNPFHVLLI 80
CeLELO .-------------------------AQQHPLVQRLLDVKFDTKRFVAIAT.GPKN.PD.E----G.KFFADHFDVTIQA 51
HELO1 .------------------------------------------.HFDASLSTYFKAL.GPRDTRVKGWFL.D.YIPTFIC 38
ZfELO .------------------------------------------.TFSHRVNSYIDSWMGPRDLRVTGWFL.DDYIPTFIF 38
GLELO VLAYLVTVFVGMQIMKNFERFEVKTFSLLHNFCLVSISAYMCGGILYEAY--QANYGLFENAADHTFKG-LPMAKMIWLF 157
CeLELO SIL.M.V..GTKWF.R.RQP.QLTIPLNIW..I.AAF.IAGAVKMTP.FFGTI..K.IVASYCKVFDFTKGENGYWV... 131
HELO1 SVI..LI.WL.PKY.R.KQP.SCRGILVVY.LG.TLL.L..FCELVTGVW..EGK.NF.CQGTRTAGESDMKIIRVL.WY 116
ZfELO TVM..LI.WM.PKY...RQAYSCRALLVPY.L..TLL.L..FYELVMSV....GG.NF.CQNTHSGGDADNR.MNVL.WY 116
GLELO YFSKIMEFVDTMIMVLKKNNRQISFLHVYHHSSIFTIWWLVTFVAPNGEAYFSAALNSFIHVIMYGYYFLSALG-FKQVS 236
CeLELO MA..LF.L...IFL..R.--.PLM...W...ILTMIYA.YSHPLT.-.FNRYGIY..FVV.AF..S....RSMK.IRVPG 207
HELO1 ....LI..M..FFFI.R...H..TV......A.MLN...F.MNWV.C.HS..G.T.......L..S..G..SVPSMRP-- 194
ZfELO ....LI..M..FFFI.R...H..T.......ATMLN...F.MNWV.C.HS..G.TF......L..S..G...VPALRP-- 194
GLELO ---FIKFYITRSQMTQFCMMSVQSSWDMYAMKVLGR-PGYPFFITALLWFYMWTMLGLFYNFYRKNAKLAKQAKAD---- 308
CeLELO .....AQA..SL.IV..IISCAVLAHLG.L.HFTNANCDFEPSVFK.AV.MDT.Y.A..V..FLQSYV.RGGKDKY.... 280
HELO1 .YLWW.K...QG.LL..VLTII.T-----SCG.IWP.CTF.LGWLYFQIG..ISLIA..T...IQTYNKKGASRRKDHLK 267
ZfELO .YLWW.K...QG.LV..VLTMF.T-----SCA.VWP.C.F.MGWLYFQIS..V.LIL..S...IQTY.KRSGSRKS.... 263
GLELO ----------------------AAKEKARKLQ 318
CeLELO .....................K.V--PKK.NN 289
HELO1 DHQNGSMAAVNGHTNSFSPLENNV.PRKLRKD 299
ZfELO DYPNG...SVNGHTNGVMSSEK-I.HRKARAD 291
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Table 1. Fatty acid compositions (percentage of total fatty
acids by weight) of S.cerevisiae transformed with
zebrafish elongase (ZfELO) or empty vector (control).
Results are means ± SD (n=4). Where indicated (*), mean
values for fatty acids in yeast transformed with ZfELO are
significantly different to control as determined by the
Student t-test (p < 0.05). nd, not detected; trace, < 0.05%.
         
Fatty acid Control  ZfELO
14:0 1.0 ± 0.6 1.3 ± 0.4
15:0 0.6 ± 0.4 0.7 ± 0.1
16:0 25.3 ± 1.7 22.0 ± 1.2 *
18:0 9.5 ± 0.4 14.8 ± 3.1 *
Total saturated 36.3 ± 2.2 38.8 ± 2.6
16:1n-7 35.2 ± 1.5 25.3 ± 4.0 *
18:1n-9 27.2 ± 3.6 27.0 ± 1.4
18:1n-7 1.1 ± 0.3 8.2 ± 1.5 *
20:1n-9 nd 0.5 ± 0.2 *
20:1n-7 nd 0.4 ± 0.2 *
22:1n-9 nd nd
22:1n-7 nd nd
24:1n-9 nd nd
Total monoenes 63.2 ± 2.0 61.3 ± 2.6
18:2n-6 trace trace
         
